Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

HK Type 4 license through Ballingal Investment Advisors Ltd. 

I'm a highly experienced sell-side analyst with in excess of 22 years of covering Asia Pacific equities, the past 19 years immersed in event strategies encompassing M&A risk arbitrage, directional long/short, stub trades and restructuring.  

My background also includes accountancy (liquidation/bankruptcy/receivership) earlier in my career and as a chief financial officer of a global commodity company based in the US and Mexico.

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

Bumrungrad Hospital Pub Co / Event-Driven

<a href="https://www.smartkarma.com/entities/bangkok-dusit-med-service" target="_blank" data-smartkarma-citation="entities:875:1" rel="noopener">Bangkok Dusit Med Service (BDMS TB)</a> has <a href="https://www.set.or.th/dat/mds_news/news/0264NWS270220200759150484E.pdf" target="_blank" rel="noopener">made</a> a Conditional Voluntary Tender Offer (CVTO) for 24.99% held <a href="https://www.smartkarma.com/entities/bumrungrad-hospital-pub-co" target="_blank" data-smartkarma-citation="entities:883:1" rel="noopener">Bumrungrad Hospital Pub Co (BH TB)</a> at THB125/share, an 11.6% premium to last close.
That Offer Price may increase by up to 20% - or up to THB150/share - depending on the "appropriateness of the market directions of the market of the Stock Exchange of Thailand and the trading price of BH at the time."
In addition to requiring approval from BDMS' shareholders, the key condition to the Offer will be the approval from the Trade Competition Commission (TCC). That is unlikely to be a defeating condition.
The initial headline price, and even the high end of this indicative range, appears highly opportunistic.
More below the fold.

Bangkok Dusit Med Service (BDMS TB) has made a Conditional Voluntary Tender Offer (CVTO) for 24.99% held Bumrungrad Hospital Pub Co (BH TB) at THB125/share, an 11.6% premium to last close.
That Offer Price may increase by up to 20% - or up to THB150/share - depending on the "appropriateness of the market directions of the market of the Stock Exchange of Thailand and the trading price of BH at the time."
In addition to requiring approval from BDMS' shareholders, the key condition to the Offer will be the approval from the Trade Competition Commission (TCC). That is unlikely to be a defeating condition.
The initial headline price, and even the high end of this indicative range, appears highly opportunistic.
More below the fold.

Bumrungrad: Bangkok Dusit's Poor Diagnosis